Immunohistochemical (IHC) markers such as preferentially expressed antigen in melanoma (PRAME), p16, human melanoma black-45 (HMB-45), and Ki-67 are critical tools for diagnostic clarification. This evidence concerns the gene MKI67 and melanoma.